Impact of TP53 status on the metabolic activation of environmental carcinogens

被引：0

作者：

Wohak, Laura U. E. ^{[1
,2
]}

Seidel, Albrecht ^{[3
]}

Phillips, David H. ^{[2
]}

Arlt, Volker M. ^{[2
]}

机构：

[1] Inst Canc Res, Sutton, Surrey, England

[2] Kings Coll London, London WC2R 2LS, England

[3] Inst Environm Carcinogens, Grosshansdorf, Germany

来源：

MUTAGENESIS | 2012年 / 27卷 / 06期

关键词：

D O I：

暂无

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

页码：803 / 804

页数：2

共 50 条

[21] TP53 status and response to chemotherapy in breast cancer [J].

Bertheau, Philippe ;

Espie, Marc ;

Turpin, Elisabeth ;

Lehmann, Jacqueline ;

Plassa, Louis-Francois ;

Varna, Mariana ;

Janin, Anne ;

de The, Hugues .

PATHOBIOLOGY, 2008, 75 (02) :132-139

[22] Is TP53 mutation status a predictive marker in medulloblastoma? [J].

Pfaff, E. ;

Remke, M. ;

Sturm, D. ;

Witt, H. ;

von Bueren, A. O. ;

Wittmann, A. ;

Schoettler, A. ;

Scheurlen, W. ;

Kulozik, A. E. ;

Witt, O. ;

von Deimling, A. ;

Rutkowski, S. ;

Hawkins, C. ;

Tabori, U. ;

Lichter, P. ;

Korshunov, A. ;

Pfister, S. M. .

KLINISCHE PADIATRIE, 2010, 222 (06) :415-415

[23] Correlation between apoptosis and TP53 status in osteosarcoma [J].

Pompetti, F ;

Stuppia, L ;

Gatta, V ;

Calabrese, G ;

Gamberi, G ;

Benassi, MS ;

Picci, P ;

Palka, G .

CANCER GENETICS AND CYTOGENETICS, 1998, 105 (02) :177-181

[24] TP53 Status and Response to Treatment in Breast Cancers [J].

Varna, Mariana ;

Bousquet, Guilhem ;

Plassa, Louis-Francois ;

Bertheau, Philippe ;

Janin, Anne .

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011, :1-9

[25] p53 immunohistochemical staining and correlation with TP53 status [J].

Viana-Errasti, J. ;

Martinez Aracil, A. P. ;

Jimenez, K. ;

Pereda, A. ;

Perez de Nanclares, G. ;

Aguirre, J. J. .

VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) :S137-S138

[26] p53/TP53 Status Assessment in Gastroesophageal Adenocarcinoma [J].

Boldrin, Elisa ;

Piano, Maria Assunta ;

Bernaudo, Francesco ;

Alfieri, Rita ;

Biasin, Maria Raffaella ;

Montagner, Isabella Monia ;

Volpato, Alice ;

Mattara, Genny ;

Lamacchia, Francesco ;

Magni, Giovanna ;

Rosato, Antonio ;

Scapinello, Antonio ;

Pilati, Pierluigi ;

Curtarello, Matteo .

CANCERS, 2023, 15 (10)

[27] Characterising Mutational Spectra of Carcinogens in the Tumour Suppressor Gene TP53 Using Human TP53 Knock-in (Hupki) Mouse Embryo Fibroblasts [J].

Hoelzl-Armstrong, Lisa ;

Kucab, Jill E. ;

Korenjak, Michael ;

Luijten, Mirjam ;

Phillips, David H. ;

Zavadil, Jiri ;

Arlt, Volker M. .

METHODS AND PROTOCOLS, 2019, 2 (04) :1-41

[28] Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA [J].

Li, Xuerui ;

Chen, Xiaoqing ;

Wen, Lingzhu ;

Wang, Yulei ;

Chen, Bo ;

Xue, Yunlian ;

Guo, Liping ;

Liao, Ning .

THORACIC CANCER, 2020, 11 (07) :1861-1868

[29] Comprehensive Identification of Deleterious TP53 Missense VUS Variants Based on Their Impact on TP53 Structural Stability [J].

Tam, Benjamin ;

Sinha, Siddharth ;

Qin, Zixin ;

Wang, San Ming .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)

[30] TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies [J].

Ruzinova, Marianna B. ;

Lee, Yi-Shan ;

Duncavage, Eric J. ;

Welch, John S. .

HAEMATOLOGICA, 2019, 104 (08) :E345-E348

← 1 2 3 4 5 →